Inadequate response to anti-TNFα therapy is associated with a gain-of-function TNFR2-R polymorphic variant in patients with psoriatic arthritis
Annals of the Rheumatic Diseases · 2025
DOI: 10.1016/j.ard.2025.10.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2025. Verfasst von James K Sullivan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Lerner College of Medicine of Case Western Reserve School of Medicine, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Receptors, Tumor Necrosis Factor, Type II, Tumor Necrosis Factor-alpha, Antirheumatic Agents. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIAMS NIH HHS, Rheumatology Research Foundation.
Abstract (Originalsprache)
OBJECTIVES: Front-line treatment for psoriatic arthritis (PsA) often involves the use of tumour necrosis factor alpha (TNFα) blocking medications (tumour necrosis factor alpha inhibition [TNFi]). However, more than 40% of patients exhibit inadequate responses, and there is no predictive clinical test available. Our goal is to investigate whether the response to TNFi treatment is associated with TNFα receptor 2 (TNFR2) rs1061622 polymorphic variants, TNFR2-M or TNFR2-R, in PsA. Furthermore, to elucidate the underlying mechanisms, differences in cell signalling and gene expression conferred by TNFR2-M vs TNFR2-R were examined. METHODS: TNFR2 rs1061622 polymorphism status of 164 patients was assessed using restriction fragment length polymorphisms analysis. Discontinuation of the TNFi agents
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve School of Medicine, Cleveland, Ohio, USA.
- Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Orthopaedic and Rheumatologic Institute, Cleveland, Ohio, USA.
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve School of Medicine, Cleveland, Ohio, USA; Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Oh…
Förderung
- NHLBI NIH HHS
- NIAMS NIH HHS
- Rheumatology Research Foundation
- Cleveland Clinic
- National Institutes of Health
- National Psoriasis Foundation
Zitieren
APA
Sullivan, J. K., Rai, V., Harvey, J., Signore, V. D., Cheemalavagu, S., Lin, J., Ithychanda, S. S., Qin, J., Chandrasekharan, U. M., & Husni, M. E. (2025). Inadequate response to anti-TNFα therapy is associated with a gain-of-function TNFR2-R polymorphic variant in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.10.014
Vancouver
Sullivan JK, Rai V, Harvey J, Signore VD, Cheemalavagu S, Lin J, et al. Inadequate response to anti-TNFα therapy is associated with a gain-of-function TNFR2-R polymorphic variant in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 2025. doi:10.1016/j.ard.2025.10.014
BibTeX
@article{Sullivan2025,
author = {Sullivan, James K and Rai, Vandana and Harvey, Jennifer and Signore, Vincent Del and Cheemalavagu, Shashank and Lin, Jean and Ithychanda, Sujay S and Qin, Jun and Chandrasekharan, Unnikrishnan M and Husni, M Elaine},
title = {Inadequate response to anti-TNFα therapy is associated with a gain-of-function TNFR2-R polymorphic variant in patients with psoriatic arthritis},
journal = {Annals of the Rheumatic Diseases},
year = {2025},
doi = {10.1016/j.ard.2025.10.014}
}
EUVIMED